Sydnexis

Sydnexis email format

Verified email-pattern data for Sydnexis is currently limited. You can still use the company insights and contact sections below.
Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence over the last 30 years. Once considered a benign refractive condition, even at low levels, myopia is now associated with many serious ophthalmic co- morbidities. The greater myopia severity, the higher the risk of these ophthalmic co-morbidities later in life. Sydnexis was founded with the goal of developing a proprietary, stable, low-dose atropine eyedrop to treat myopia progression in children and minimize the risk of ocular co-morbidities. At Sydnexis, we have focused on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.

Company Details

Employees
21
Founded
-
Address
Del Mar, California
Industry
Pharmaceutical Manufacturing
HQ
Del Mar, California
Looking for a particular Sydnexis employee's phone or email?

Sydnexis Questions

Explore related pages

Related company profiles:

Top Sydnexis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant